HEATHER SIEBERS: Open Payments
NPI 1528274594 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 31 payments from 12 companies in 2025. Trend: 2023 $473 · 2024 $368 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $102 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $83 |
| ABBVIE INC. | 4 | $83 |
| Evofem Biosciences, Inc. | 4 | $74 |
| Sage Therapeutics, LLC | 3 | $73 |
| Astellas Pharma US Inc | 2 | $40 |
| Exeltis, USA Inc. | 2 | $34 |
| Organon LLC | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $22 |
Products named: MYFEMBREE, Phexxi, ZURZUVAE, LILETTA, Veozah, SLYND, NEXPLANON, Qelbree.
Industry payments across MO — which companies pay providers there.
